Altimmune, Inc. (ALT) stock price moved 16.16% away from 20-Days Simple Moving Average, -11.39% from 50-Days Simple Moving Average and separated -76.63% from 200 Days Simple Moving Average. Altimmune, Inc. (ALT) reported loss -4.29% in recent buying and selling session with closing price of $ 2.68. The stock’s traded 0.13 million shares in session while it holds an average volume of 0.59 million shares. The ALT switched 57.65% away from its 52 week minimum and distanced -95.60% from its 52 week peak. The volatility change in the previous week has observed by 7.64% and experienced of 12.81% change in the last month.
The short ratio in the company’s stock is documented at 0.86 and the short float is around of 6.48%. Beta factor, which measures the riskiness of the security, was registered at 3.15. The Company kept a record of 7.88 million floated shares and 9.14 million shares outstanding. The average true range of the stock is observed at 0.26 and the relative strength index of the stock is recorded at 50.88.
Altimmune, Inc. (ALT) Stock Profitability Levels:
The company made Return on equity of -74.20% in last 12 months period. Return on assets ratio of the Company was -50.40%. Its return on investment ratio was -114.90% in the trailing 12 months period.
The Company’s sales have grown at an average annualized rate of about -15.70% during the past five years. For the past 5 years, The Company’s EPS growth has been nearly -31.00%. Analyst established EPS growth expected to grow of -136.70% for this year.
Looking about the past performance history, the company plunged 2.29% for the last five trades and exhausted -12.13% in one month period. The stock deteriorated -41.61% during the past three month period and discounted -80.32% in half year. During the yearly overview it downgraded -95.49% and shown 30.10% year to date performance.